IQV NYSE
Credit Risk of going bust: lower than 51% of companies Debt: 26.5% of company value Bonds: $734.0M held by 498 funds, 76 bp over Treasuries → details ▾
If the stock fell to about $8.48 (down 97%), IQVIA Holdings Inc. would be worth roughly what it owes.
Total debt $16.24B against a stock market value of $44.98B.
Distance to default 5.24 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $9.15B (short-term plus half of long-term), stock volatility 40.1%; Altman Z'' 1.10. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Durham, NC 27703
US
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Berkshire James G. | M-Exempt | 5,381 | $131.82 | 2026-09-02 |
| Berkshire James G. | S-Sale | 2,668 | $261.33 | 2026-09-02 |
| Berkshire James G. | D-Return | 2,713 | $261.54 | 2026-09-02 |
| Berkshire James G. | M-Exempt | 5,381 | $131.82 | 2026-09-02 |
| STAUB W RICHARD | S-Sale | 5,500 | $232.68 | 2026-08-03 |